Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,882.03
(
0.82%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

zipjet

Send PM Follow Ignore
Followers 36
Posts 2637
Boards Moderated 0
Alias Born 10/06/2003

zipjet

Re: biopearl post# 127022

Wednesday, 09/21/2011 3:14:23 PM

Wednesday, September 21, 2011 3:14:23 PM

Post# of 257302

Zip so why can't Amphastar start at the same place Sanofi does and end at the same place too would that violate Sanofi patents?



It is very different to take a recipe and make a product than to take that product, reverse-engineer it and prove it is the same. IF in the process of reverse-engineering and proof of sameness Amphastar/TEVA used the MNTA patented process then it could lead to blocking the launch* or a court ordered royalty for the use of the patent.

ij

* Of course, negotiated settlements are also possible.

It is astonishing what foolish things one can temporarily believe if one thinks too long alone ... where it is often impossible to bring one's ideas to a conclusive test either formal or experimental. J.M. Keynes

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today